Edition:
United Kingdom

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

33.88USD
17 Aug 2018
Change (% chg)

$-0.03 (-0.09%)
Prev Close
$33.91
Open
$33.91
Day's High
$34.85
Day's Low
$33.17
Volume
1,166,177
Avg. Vol
606,096
52-wk High
$35.03
52-wk Low
$2.14

Latest Key Developments (Source: Significant Developments)

Tandem Diabetes Care Sees FY 2018 Sales Up 30 To 38 Percent
Monday, 30 Jul 2018 

July 30 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 SALES $34.1 MILLION VERSUS I/B/E/S VIEW $29.7 MILLION.SEES FY 2018 SALES UP 30 TO 38 PERCENT.SEES FY 2018 SALES $140 MILLION TO $148 MILLION.QUARTERLY GAAP LOSS PER SHARE $1.17.Q2 EARNINGS PER SHARE VIEW $-0.35 -- THOMSON REUTERS I/B/E/S.  Full Article

Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES PRELIMINARY 2017 RESULTS AND PROVIDES 2018 GUIDANCE.SEES FY 2018 SALES $132 MILLION TO $140 MILLION.SEES FY 2018 SALES UP ABOUT 23 TO 32 PERCENT.- PRELIMINARY Q4 ‍GAAP SALES INCREASED TO APPROXIMATELY $39 MILLION TO $40 MILLION FROM $28.9 MILLION IN 2016​.TANDEM DIABETES CARE - EXPECT Q4 PUMP SHIPMENTS INCREASED TO ABOUT 7,000 PUMPS.- 2018 GAAP SALES ARE ESTIMATED TO BE IN RANGE OF $132 MILLION TO $140 MILLION.FY2018 REVENUE VIEW $133.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Tandem Diabetes Care Says May Offer Combination Of Stock Not Exceeding $10.7 Mln
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE SAYS MAY OFFER COMBINATION OF STOCK, PREFERRED STOCK, WARRANTS OR UNITS HAVING INITIAL OFFERING PRICE NOT EXCEEDING $10.7 MILLION.  Full Article

Tandem Diabetes Care Announces Retirement Of CFO And Successor Appointment
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Tandem Diabetes Care Inc ::TANDEM DIABETES CARE ANNOUNCES RETIREMENT OF CFO AND SUCCESSOR APPOINTMENT.SAYS CFO JOHN CAJIGAS TO RETIRE, EFFECTIVE DECEMBER 31, 2017.TANDEM DIABETES CARE SAYS LEIGH VOSSELLER, WILL BE PROMOTED TO CFO, EFFECTIVE JANUARY 1, 2018.  Full Article

Tandem Diabetes Care reports Q3 sales of $27 million
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Tandem Diabetes Care Inc :Tandem Diabetes Care reports third quarter 2017 financial results.Q3 sales $27 million versus I/B/E/S view $25.9 million.Tandem Diabetes Care Inc - qtrly loss per share $3.09‍​.Tandem Diabetes Care Inc - sees ‍fy 2017 GAAP sales to be in range of $100 million to $105 million.Tandem Diabetes Care Inc - sees ‍fy 2017 non-GAAP sales to be in range of $95 million to $100 million​.Q3 earnings per share view $-3.74, revenue view $25.9 million -- Thomson Reuters I/B/E/S.  Full Article

‍Tandem Diabetes Care to provide all t:slim X2 insulin pump features approved in 2018 to users at no cost
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Tandem Diabetes Care Inc ::‍Tandem Diabetes Care to provide all t:slim x2 insulin pump features approved in 2018 to users at no cost, expands existing dexcom welcome offer for animas customers​.Tandem diabetes care inc - ‍tandem and Dexcom are now extending terms of their welcome programs for animas customers through march 31, 2018​.  Full Article

Empery Asset Management reports 5.63 pct passive stake in Tandem Diabetes Care
Friday, 20 Oct 2017 

Oct 20 (Reuters) - Empery Asset Management Lp::Empery Asset Management Lp reports 5.63 pct passive stake in Tandem Diabetes Care Inc <<>> as of Oct 13 - SEC filing‍​.  Full Article

Tandem Diabetes Care sees Q3 sales of about $26.5 mln to $27.5 mln
Friday, 13 Oct 2017 

Oct 13 (Reuters) - Tandem Diabetes Care Inc ::Sees Q3 sales about $26.5 million to $27.5 million - sec filing.Tandem Diabetes - expect seasonality to have similar impact on sales in 2017.Tandem - ‍do not expect funding from completed or proposed financing to fully address substantial doubt about co's ability to continue as a going concern​.Tandem Diabetes-expectation of seasonality impact excludes about $3.5 million deferred sales&upgrade fees received with technology program expected in q3​.Tandem Diabetes Care Inc- ‍expect we will be required to raise additional capital in order to continue as a going concern​.  Full Article

Tandem Diabetes Care‍ shareholders approv reverse stock split
Monday, 9 Oct 2017 

Oct 9 (Reuters) - Tandem Diabetes Care Inc :Tandem Diabetes Care Inc- ‍ shareholders subsequently approved reverse stock split at a ratio of 1-for-10​.  Full Article

Tandem Diabetes Care now taking orders for t:slim X2 Insulin Pump
Tuesday, 4 Oct 2016 

Tandem Diabetes Care Inc : Tandem Diabetes Care now taking orders for next-generation t:slim X2 Insulin Pump .Shipments of t:slim X2 Pump are expected to begin late October 2016.  Full Article

BRIEF-Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump

* TANDEM DIABETES CARE-ANNOUNCED RECEIPT OF CE MARK APPROVAL FOR T:SLIM X2 INSULIN PUMP WITH DEXCOM G5® MOBILE CONTINUOUS GLUCOSE MONITORING INTEGRATION